- Home
- LSF vs INO Comparison
LSF vs INO Comparison
Compare LSF & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- INO
- Stock Information
- Founded
- LSF 2015
- INO 1979
- Country
- LSF United States
- INO United States
- Employees
- LSF N/A
- INO N/A
- Industry
- LSF Packaged Foods
- INO Medical/Dental Instruments
- Sector
- LSF Consumer Staples
- INO Health Care
- Exchange
- LSF Nasdaq
- INO Nasdaq
- Market Cap
- LSF 65.5M
- INO 69.3M
- IPO Year
- LSF 2020
- INO 1998
- Fundamental
- Price
- LSF $5.97
- INO $1.96
- Analyst Decision
- LSF Strong Buy
- INO Buy
- Analyst Count
- LSF 2
- INO 5
- Target Price
- LSF $12.00
- INO $8.80
- AVG Volume (30 Days)
- LSF 53.5K
- INO 1.9M
- Earning Date
- LSF 08-06-2025
- INO 08-12-2025
- Dividend Yield
- LSF N/A
- INO N/A
- EPS Growth
- LSF N/A
- INO N/A
- EPS
- LSF N/A
- INO N/A
- Revenue
- LSF $47,027,546.00
- INO $182,337.00
- Revenue This Year
- LSF $22.13
- INO N/A
- Revenue Next Year
- LSF $20.71
- INO $20,588.06
- P/E Ratio
- LSF N/A
- INO N/A
- Revenue Growth
- LSF 22.79
- INO N/A
- 52 Week Low
- LSF $3.40
- INO $1.30
- 52 Week High
- LSF $10.90
- INO $7.76
- Technical
- Relative Strength Index (RSI)
- LSF 44.37
- INO 66.94
- Support Level
- LSF $5.55
- INO $1.80
- Resistance Level
- LSF $6.71
- INO $2.08
- Average True Range (ATR)
- LSF 0.44
- INO 0.12
- MACD
- LSF -0.06
- INO 0.06
- Stochastic Oscillator
- LSF 26.42
- INO 82.35
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.